Loading...

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

BACKGROUND: In the Women’s Health Initiative (WHI) randomized trial, estrogen plus progestin increased both breast cancer incidence and mortality. In contrast, most observational studies associate estrogen plus progestin with favorable prognosis breast cancers. To address differences, a cohort of WH...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Chlebowski, Rowan T., Manson, JoAnn E., Anderson, Garnet L., Cauley, Jane A., Aragaki, Aaron K., Stefanick, Marcia L., Lane, Dorothy S., Johnson, Karen C., Wactawski-Wende, Jean, Chen, Chu, Qi, Lihong, Yasmeen, Shagufta, Newcomb, Polly A., Prentice, Ross L.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691942/
https://ncbi.nlm.nih.gov/pubmed/23543779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt043
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!